Selected research
Market Analysis & Forecast
Global Avuncular DNA Tests Market Analysis and Forecast 2026-2032
Market perspective
The global Avuncular DNA Tests market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Avuncular DNA Tests is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Avuncular DNA Tests is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Avuncular DNA Tests is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Avuncular DNA Tests is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Avuncular DNA Tests include AlphaBiolabs, NorthGene, International Biosciences, EasyDNA, DNA Worldwide, GTLDNA, Cellmark, PaternityUSA and EDC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Avuncular DNA Tests, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Avuncular DNA Tests, also provides the revenue of main regions and countries. Of the upcoming market potential for Avuncular DNA Tests, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Avuncular DNA Tests revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Avuncular DNA Tests market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Avuncular DNA Tests revenue, projected growth trends, production technology, application and end-user industry.
Avuncular DNA Tests Segment by Company
AlphaBiolabs
NorthGene
International Biosciences
EasyDNA
DNA Worldwide
GTLDNA
Cellmark
PaternityUSA
EDC
Brooklyn DNA Testing
Test Me DNA
Upstate DNA
Test Smartly Labs
Eurofins
The Carlson Company
DNA Direct Solutions
Avuncular DNA Tests Segment by Type
Saliva Sample
Blood Sample
Avuncular DNA Tests Segment by Application
Hospitals
Testing Organizations
Others
Avuncular DNA Tests Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Avuncular DNA Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Avuncular DNA Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Avuncular DNA Tests.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Avuncular DNA Tests in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Avuncular DNA Tests company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Avuncular DNA Tests revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Saliva Sample
- Blood Sample
Applications
- Hospitals
- Testing Organizations
- Others
Companies covered
- AlphaBiolabs
- NorthGene
- International Biosciences
- EasyDNA
- DNA Worldwide
- GTLDNA
- Cellmark
- PaternityUSA
- EDC
- Brooklyn DNA Testing
- Test Me DNA
- Upstate DNA
- Test Smartly Labs
- Eurofins
- The Carlson Company
- DNA Direct Solutions
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Avuncular DNA Tests Market by Type
- 1.2.1 Global Avuncular DNA Tests Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Saliva Sample
- 1.2.3 Blood Sample
- 1.3 Avuncular DNA Tests Market by Application
- 1.3.1 Global Avuncular DNA Tests Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospitals
- 1.3.3 Testing Organizations
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Avuncular DNA Tests Market Dynamics
- 2.1 Avuncular DNA Tests Industry Trends
- 2.2 Avuncular DNA Tests Industry Drivers
- 2.3 Avuncular DNA Tests Industry Opportunities and Challenges
- 2.4 Avuncular DNA Tests Industry Restraints
3 Global Growth Perspective
- 3.1 Global Avuncular DNA Tests Market Perspective (2021-2032)
- 3.2 Global Avuncular DNA Tests Growth Trends by Region
- 3.2.1 Global Avuncular DNA Tests Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Avuncular DNA Tests Market Size by Region (2021-2026)
- 3.2.3 Global Avuncular DNA Tests Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Avuncular DNA Tests Revenue by Players
- 4.1.1 Global Avuncular DNA Tests Revenue by Players (2021-2026)
- 4.1.2 Global Avuncular DNA Tests Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Avuncular DNA Tests Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Avuncular DNA Tests Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Avuncular DNA Tests Key Players Headquarters & Area Served
- 4.4 Global Avuncular DNA Tests Players, Product Type & Application
- 4.5 Global Avuncular DNA Tests Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Avuncular DNA Tests Market CR5 and HHI
- 4.6.3 2025 Avuncular DNA Tests Tier 1, Tier 2, and Tier 3
5 Avuncular DNA Tests Market Size by Type
- 5.1 Global Avuncular DNA Tests Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Avuncular DNA Tests Revenue by Type (2021-2032)
- 5.3 Global Avuncular DNA Tests Revenue Market Share by Type (2021-2032)
6 Avuncular DNA Tests Market Size by Application
- 6.1 Global Avuncular DNA Tests Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Avuncular DNA Tests Revenue by Application (2021-2032)
- 6.3 Global Avuncular DNA Tests Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 AlphaBiolabs
- 7.1.1 AlphaBiolabs Company Information
- 7.1.2 AlphaBiolabs Business Overview
- 7.1.3 AlphaBiolabs Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.1.4 AlphaBiolabs Avuncular DNA Tests Product Portfolio
- 7.1.5 AlphaBiolabs Recent Developments
- 7.2 NorthGene
- 7.2.1 NorthGene Company Information
- 7.2.2 NorthGene Business Overview
- 7.2.3 NorthGene Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.2.4 NorthGene Avuncular DNA Tests Product Portfolio
- 7.2.5 NorthGene Recent Developments
- 7.3 International Biosciences
- 7.3.1 International Biosciences Company Information
- 7.3.2 International Biosciences Business Overview
- 7.3.3 International Biosciences Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.3.4 International Biosciences Avuncular DNA Tests Product Portfolio
- 7.3.5 International Biosciences Recent Developments
- 7.4 EasyDNA
- 7.4.1 EasyDNA Company Information
- 7.4.2 EasyDNA Business Overview
- 7.4.3 EasyDNA Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.4.4 EasyDNA Avuncular DNA Tests Product Portfolio
- 7.4.5 EasyDNA Recent Developments
- 7.5 DNA Worldwide
- 7.5.1 DNA Worldwide Company Information
- 7.5.2 DNA Worldwide Business Overview
- 7.5.3 DNA Worldwide Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.5.4 DNA Worldwide Avuncular DNA Tests Product Portfolio
- 7.5.5 DNA Worldwide Recent Developments
- 7.6 GTLDNA
- 7.6.1 GTLDNA Company Information
- 7.6.2 GTLDNA Business Overview
- 7.6.3 GTLDNA Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.6.4 GTLDNA Avuncular DNA Tests Product Portfolio
- 7.6.5 GTLDNA Recent Developments
- 7.7 Cellmark
- 7.7.1 Cellmark Company Information
- 7.7.2 Cellmark Business Overview
- 7.7.3 Cellmark Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.7.4 Cellmark Avuncular DNA Tests Product Portfolio
- 7.7.5 Cellmark Recent Developments
- 7.8 PaternityUSA
- 7.8.1 PaternityUSA Company Information
- 7.8.2 PaternityUSA Business Overview
- 7.8.3 PaternityUSA Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.8.4 PaternityUSA Avuncular DNA Tests Product Portfolio
- 7.8.5 PaternityUSA Recent Developments
- 7.9 EDC
- 7.9.1 EDC Company Information
- 7.9.2 EDC Business Overview
- 7.9.3 EDC Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.9.4 EDC Avuncular DNA Tests Product Portfolio
- 7.9.5 EDC Recent Developments
- 7.10 Brooklyn DNA Testing
- 7.10.1 Brooklyn DNA Testing Company Information
- 7.10.2 Brooklyn DNA Testing Business Overview
- 7.10.3 Brooklyn DNA Testing Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.10.4 Brooklyn DNA Testing Avuncular DNA Tests Product Portfolio
- 7.10.5 Brooklyn DNA Testing Recent Developments
- 7.11 Test Me DNA
- 7.11.1 Test Me DNA Company Information
- 7.11.2 Test Me DNA Business Overview
- 7.11.3 Test Me DNA Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.11.4 Test Me DNA Avuncular DNA Tests Product Portfolio
- 7.11.5 Test Me DNA Recent Developments
- 7.12 Upstate DNA
- 7.12.1 Upstate DNA Company Information
- 7.12.2 Upstate DNA Business Overview
- 7.12.3 Upstate DNA Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.12.4 Upstate DNA Avuncular DNA Tests Product Portfolio
- 7.12.5 Upstate DNA Recent Developments
- 7.13 Test Smartly Labs
- 7.13.1 Test Smartly Labs Company Information
- 7.13.2 Test Smartly Labs Business Overview
- 7.13.3 Test Smartly Labs Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.13.4 Test Smartly Labs Avuncular DNA Tests Product Portfolio
- 7.13.5 Test Smartly Labs Recent Developments
- 7.14 Eurofins
- 7.14.1 Eurofins Company Information
- 7.14.2 Eurofins Business Overview
- 7.14.3 Eurofins Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.14.4 Eurofins Avuncular DNA Tests Product Portfolio
- 7.14.5 Eurofins Recent Developments
- 7.15 The Carlson Company
- 7.15.1 The Carlson Company Company Information
- 7.15.2 The Carlson Company Business Overview
- 7.15.3 The Carlson Company Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.15.4 The Carlson Company Avuncular DNA Tests Product Portfolio
- 7.15.5 The Carlson Company Recent Developments
- 7.16 DNA Direct Solutions
- 7.16.1 DNA Direct Solutions Company Information
- 7.16.2 DNA Direct Solutions Business Overview
- 7.16.3 DNA Direct Solutions Avuncular DNA Tests Revenue and Gross Margin (2021-2026)
- 7.16.4 DNA Direct Solutions Avuncular DNA Tests Product Portfolio
- 7.16.5 DNA Direct Solutions Recent Developments
8 North America
- 8.1 North America Avuncular DNA Tests Revenue (2021-2032)
- 8.2 North America Avuncular DNA Tests Revenue by Type (2021-2032)
- 8.2.1 North America Avuncular DNA Tests Revenue by Type (2021-2026)
- 8.2.2 North America Avuncular DNA Tests Revenue by Type (2027-2032)
- 8.3 North America Avuncular DNA Tests Revenue Share by Type (2021-2032)
- 8.4 North America Avuncular DNA Tests Revenue by Application (2021-2032)
- 8.4.1 North America Avuncular DNA Tests Revenue by Application (2021-2026)
- 8.4.2 North America Avuncular DNA Tests Revenue by Application (2027-2032)
- 8.5 North America Avuncular DNA Tests Revenue Share by Application (2021-2032)
- 8.6 North America Avuncular DNA Tests Revenue by Country
- 8.6.1 North America Avuncular DNA Tests Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Avuncular DNA Tests Revenue by Country (2021-2026)
- 8.6.3 North America Avuncular DNA Tests Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Avuncular DNA Tests Revenue (2021-2032)
- 9.2 Europe Avuncular DNA Tests Revenue by Type (2021-2032)
- 9.2.1 Europe Avuncular DNA Tests Revenue by Type (2021-2026)
- 9.2.2 Europe Avuncular DNA Tests Revenue by Type (2027-2032)
- 9.3 Europe Avuncular DNA Tests Revenue Share by Type (2021-2032)
- 9.4 Europe Avuncular DNA Tests Revenue by Application (2021-2032)
- 9.4.1 Europe Avuncular DNA Tests Revenue by Application (2021-2026)
- 9.4.2 Europe Avuncular DNA Tests Revenue by Application (2027-2032)
- 9.5 Europe Avuncular DNA Tests Revenue Share by Application (2021-2032)
- 9.6 Europe Avuncular DNA Tests Revenue by Country
- 9.6.1 Europe Avuncular DNA Tests Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Avuncular DNA Tests Revenue by Country (2021-2026)
- 9.6.3 Europe Avuncular DNA Tests Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Avuncular DNA Tests Revenue (2021-2032)
- 10.2 China Avuncular DNA Tests Revenue by Type (2021-2032)
- 10.2.1 China Avuncular DNA Tests Revenue by Type (2021-2026)
- 10.2.2 China Avuncular DNA Tests Revenue by Type (2027-2032)
- 10.3 China Avuncular DNA Tests Revenue Share by Type (2021-2032)
- 10.4 China Avuncular DNA Tests Revenue by Application (2021-2032)
- 10.4.1 China Avuncular DNA Tests Revenue by Application (2021-2026)
- 10.4.2 China Avuncular DNA Tests Revenue by Application (2027-2032)
- 10.5 China Avuncular DNA Tests Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Avuncular DNA Tests Revenue (2021-2032)
- 11.2 Asia Avuncular DNA Tests Revenue by Type (2021-2032)
- 11.2.1 Asia Avuncular DNA Tests Revenue by Type (2021-2026)
- 11.2.2 Asia Avuncular DNA Tests Revenue by Type (2027-2032)
- 11.3 Asia Avuncular DNA Tests Revenue Share by Type (2021-2032)
- 11.4 Asia Avuncular DNA Tests Revenue by Application (2021-2032)
- 11.4.1 Asia Avuncular DNA Tests Revenue by Application (2021-2026)
- 11.4.2 Asia Avuncular DNA Tests Revenue by Application (2027-2032)
- 11.5 Asia Avuncular DNA Tests Revenue Share by Application (2021-2032)
- 11.6 Asia Avuncular DNA Tests Revenue by Country
- 11.6.1 Asia Avuncular DNA Tests Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Avuncular DNA Tests Revenue by Country (2021-2026)
- 11.6.3 Asia Avuncular DNA Tests Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Avuncular DNA Tests Revenue (2021-2032)
- 12.2 SAMEA Avuncular DNA Tests Revenue by Type (2021-2032)
- 12.2.1 SAMEA Avuncular DNA Tests Revenue by Type (2021-2026)
- 12.2.2 SAMEA Avuncular DNA Tests Revenue by Type (2027-2032)
- 12.3 SAMEA Avuncular DNA Tests Revenue Share by Type (2021-2032)
- 12.4 SAMEA Avuncular DNA Tests Revenue by Application (2021-2032)
- 12.4.1 SAMEA Avuncular DNA Tests Revenue by Application (2021-2026)
- 12.4.2 SAMEA Avuncular DNA Tests Revenue by Application (2027-2032)
- 12.5 SAMEA Avuncular DNA Tests Revenue Share by Application (2021-2032)
- 12.6 SAMEA Avuncular DNA Tests Revenue by Country
- 12.6.1 SAMEA Avuncular DNA Tests Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Avuncular DNA Tests Revenue by Country (2021-2026)
- 12.6.3 SAMEA Avuncular DNA Tests Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst